Print Page  |  Close Window
Array BioPharma is creating the next generation of orally active drugs
 

Welcome to Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Latest News and Press Releases:
9/7/2010 Array BioPharma to Present at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference
8/9/2010 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2010
8/3/2010 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2010 on August 9, 2010
6/5/2010 Array BioPharma's ARRY-520Well Tolerated and Demonstrates Preliminary Activity as a Single Agent in Multiple Myeloma Patients